Tirzepatide glaucoma risk was lower than with selective glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus ...
Glaucoma has a reputation as the "silent thief of sight," and for good reason. It is one of the leading causes of ...
A risk score incorporating genetic variants for open-angle glaucoma is accurate enough to help with diagnosis of the condition, an interim study reveals. Although hundreds of genetic changes are ...
DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results from two ...
In patients without diabetes diagnosed with overweight or obesity, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) led to a greater reduction in the risks for primary open-angle ...
Regardless of whether it is a swept-source or spectral-domain platform, OCT angiography is comparably useful for monitoring ...
Combating the ‘Silent Thief of Sight’ As part of January’s National Glaucoma Awareness Month, Prevent Blindness, the nation’s ...
Glaucoma is the term for a group of eye conditions that damage the optic nerve at the back of the eye. Without treatment, it can lead to vision loss and blindness. Glaucoma is not a life threatening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback